Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ENZ
- Price
- 0.54
- Stock movement down
- -0.00 (-0.02%)
- Company name
- Enzo Biochem Inc
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 28.29M
- Ent value
- 5.57M
- Price/Sales
- 0.89
- Price/Book
- 0.50
- Div yield
- 74.09%
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -53.46%
- 3 year return
- -37.20%
- 5 year return
- -24.83%
- 10 year return
- -15.82%
Last updated: 2025-09-12
DIVIDENDS
ENZ does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 3.35 |
| EV to EBITDA | 0.66 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.89 |
| Price to Book | 0.50 |
| EV to Sales | 0.17 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 52.40M |
| EPS (TTM) | -0.50 |
| FCF per share (TTM) | -0.59 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 31.91M |
| Gross profit (TTM) | 14.63M |
| Operating income (TTM) | -10.92M |
| Net income (TTM) | -26.08M |
| EPS (TTM) | -0.50 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 45.86% |
| Operating margin (TTM) | -34.21% |
| Profit margin (TTM) | -81.73% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 52.37M |
| Net receivables | 3.99M |
| Total current assets | 70.03M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 32.00M |
| Total assets | 85.76M |
| Accounts payable | 1.38M |
| Short/Current long term debt | 3.51M |
| Total current liabilities | 24.79M |
| Total liabilities | 29.65M |
| Shareholder's equity | 56.11M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -26.26M |
| Capital expenditures (TTM) | 545.00K |
| Free cash flow (TTM) | -30.78M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -46.47% |
| Return on Assets | -30.41% |
| Return on Invested Capital | -45.58% |
| Cash Return on Invested Capital | -53.79% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.53 |
| Daily high | 0.54 |
| Daily low | 0.51 |
| Daily Volume | 2K |
| All-time high | 100.37 |
| 1y analyst estimate | 5.50 |
| Beta | 1.16 |
| EPS (TTM) | -0.50 |
| Dividend per share | 0.40 |
| Ex-div date | 15 Nov 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ENZ | S&P500 | |
| Current price drop from All-time high | -99.46% | -2.53% |
| Highest price drop | -99.74% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -75.15% | -10.99% |
| Avg time to new high | 139 days | 12 days |
| Max time to new high | 6391 days | 1805 days |
COMPANY DETAILS
Marketcap
28.29M
Marketcap category
Small-cap
Description
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Employees
125
Website
Investor relations
SEC filings
CEO
Elazar Rabbani
Country
USA
City
New York
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner